XML 39 R22.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Taxes
12 Months Ended
Dec. 31, 2018
Income Tax Disclosure [Abstract]  
INCOME TAXES
INCOME TAXES
The net income tax benefit differs from the amount computed by applying the statutory federal income tax rate to CTRS' income before taxes follows ($ in thousands):
 
2018
 
2017
 
2016
 
Amount
 
Rate
 
Amount
 
Rate
 
Amount
 
Rate
Federal income tax benefit (expense)
$
143

 
21
 %
 
$
47

 
35
 %
 
$
(1,159
)
 
(35
)%
State income tax benefit (expense), net of federal income tax effect
27

 
4
 %
 
5

 
4
 %
 
(132
)
 
(4
)%
Change in deferred tax assets as a result of change in tax law

 
 %
 
(340
)
 
(254
)%
 

 
 %
Valuation allowance
(174
)
 
(26
)%
 
283

 
211
 %
 
1,282

 
39
 %
Other
4

 
1
 %
 
5

 
4
 %
 
9

 
 %
Benefit applicable to income (loss) from continuing operations
$

 
 %
 
$

 
 %
 
$

 
 %

The tax effect of significant temporary differences representing deferred tax assets and liabilities of CTRS as of December 31, 2018 and 2017 are as follows (in thousands):
 
2018
 
2017
Income from unconsolidated joint ventures
$
18

 
$
19

Federal and state tax carryforwards
763

 
590

Other
2

 

Total deferred tax assets
783

 
609

Valuation allowance
(783
)
 
(609
)
Net deferred tax asset
$

 
$


A valuation allowance is required to be recorded against deferred tax assets if, based on the available evidence, it is more likely than not that such assets will not be realized. When assessing the need for a valuation allowance, appropriate consideration should be given to all positive and negative evidence related to this realization. This evidence includes, among other things, the existence of current and recent cumulative losses, forecasts of future profitability, the length of statutory carryforward periods, the Company’s history with loss carryforwards and available tax planning strategies.
As of December 31, 2018 and 2017 the deferred tax asset of CTRS equaled $783,000 and $609,000, respectively, with a valuation allowance placed against the full amount of each. The conclusion that a valuation allowance should be recorded as of December 31, 2018 and 2017 was based on the lack of evidence that CTRS could generate future taxable income to realize the benefit of the deferred tax assets.